AU2170692A - Me20: monoclonal antibodies and antigen for human melanoma - Google Patents

Me20: monoclonal antibodies and antigen for human melanoma

Info

Publication number: AU2170692A
Authority: AU; Australia
Prior art keywords: antigen; monoclonal antibodies; human melanoma; melanoma; human
Prior art date: 1991-06-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU21706/92A

Inventor

Ingegerd Hellstrom

Karl Erik Hellstrom

Hans Marquardt

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bristol Myers Squibb Co

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-06-05

Filing date

1992-05-27

Publication date

1993-01-08

1992-05-27 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

1993-01-08 Publication of AU2170692A publication Critical patent/AU2170692A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3053—Skin, nerves, brain
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Cell Biology (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AU21706/92A 1991-06-05 1992-05-27 Me20: monoclonal antibodies and antigen for human melanoma Abandoned AU2170692A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US71061391A	1991-06-05	1991-06-05
US710613		1996-09-20

Publications (1)

Publication Number	Publication Date
AU2170692A true AU2170692A (en)	1993-01-08

Family

ID=24854790

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU21706/92A Abandoned AU2170692A (en)	1991-06-05	1992-05-27	Me20: monoclonal antibodies and antigen for human melanoma

Country Status (7)

Country	Link
AU (1)	AU2170692A (en)
IE (1)	IE921810A1 (en)
IL (1)	IL102088A0 (en)
MX (1)	MX9202642A (en)
PT (1)	PT100568A (en)
WO (1)	WO1992021767A1 (en)
ZA (1)	ZA924068B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995029193A2 (en) *	1994-04-22	1995-11-02	The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services	Melanoma antigens
US5874560A (en) *	1994-04-22	1999-02-23	The United States Of America As Represented By The Department Of Health And Human Services	Melanoma antigens and their use in diagnostic and therapeutic methods
US20040156861A1 (en)	1996-07-11	2004-08-12	Figdor Carl Gustav	Melanoma associated peptide analogues and vaccines against melanoma
AT502292B1 (en)	2005-05-11	2010-04-15	Avir Green Hills Biotechnology	MELANOMA DIAGNOSIS
US20110300067A1 (en) *	2008-09-09	2011-12-08	Ekaterina Dadachova	Methods for increasing efficacy of radioimmunotherapy of melanoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1339798C (en) *	1985-02-01	1998-04-07	Alan N. Houghton	Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans
GB2188637B (en) *	1986-02-07	1990-11-14	Oncogen	Vaccines against melanoma

1992
- 1992-05-27 AU AU21706/92A patent/AU2170692A/en not_active Abandoned
- 1992-05-27 WO PCT/US1992/004451 patent/WO1992021767A1/en active Application Filing
- 1992-06-03 MX MX9202642A patent/MX9202642A/en unknown
- 1992-06-03 IL IL102088A patent/IL102088A0/en unknown
- 1992-06-04 PT PT100568A patent/PT100568A/en not_active Application Discontinuation
- 1992-06-04 ZA ZA924068A patent/ZA924068B/en unknown
- 1992-07-01 IE IE181092A patent/IE921810A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
PT100568A (en)	1993-09-30
MX9202642A (en)	1992-12-01
IL102088A0 (en)	1993-01-14
ZA924068B (en)	1993-02-24
IE921810A1 (en)	1992-12-16
WO1992021767A1 (en)	1992-12-10

Similar Documents

Publication	Publication Date	Title
ZA949341B (en)	1996-05-24	Humanized antibodies and uses thereof
AU645187B2 (en)	1994-01-06	Freeze-dried preparation containing monoclonal antibody
AU3107289A (en)	1989-09-14	Chimeric antibodies directed against human carcinoembryonic antigen
AU4042195A (en)	1996-06-27	Anti-alphaV-integrin monoclonal antibody
IL108199A0 (en)	1994-04-12	Monoclonal antibodies against the human il-4 receptor and hybridomas producing the same
AU1704099A (en)	1999-06-15	Monoclonal human natural antibodies
AU1289795A (en)	1995-06-06	Monoclonal antibodies specific for human interleukin-5
AU5365296A (en)	1996-10-02	Human monoclonal antibody against lung carcinoma
AU4618193A (en)	1994-03-17	Humanized antibodies
EP0580859A4 (en)	1994-09-14	Anti-eda monoclonal antibody
AU2097592A (en)	1992-10-29	Fibrinogen-specific monoclonal antibody and uses thereof
AU6155896A (en)	1996-12-30	Humanized antibodies to e-selectin
AU1423892A (en)	1992-09-07	Monoclonal antibodies directed towards mycobacterial antigens
EP0977590A4 (en)	2001-03-14	Human monoclonal antibodies
AU4274293A (en)	1993-11-29	Human monoclonal antibodies against cytomegalovirus and method for preparation thereof
AU3923293A (en)	1993-10-21	Human monoclonal antibodies and methods for human monoclonal antibody production
AU2170692A (en)	1993-01-08	Me20: monoclonal antibodies and antigen for human melanoma
AU7014294A (en)	1994-11-08	Human monoclonal antibodies and processes and materials for making such antibodies
AU657504B2 (en)	1995-03-16	Antibody against human plasmin-alpha2-plasmin inhibitor complex, hybridoma and immunoassay
AU9143991A (en)	1992-07-08	Monoclonal antibody op-g2 and method of use
EP0508282A3 (en)	1993-02-10	Anti-idiotypic monoclonal antibodies
AU2828795A (en)	1996-01-15	Monoclonal antibodies for the reduction of anti-xenogeneic immune responses
AU5852094A (en)	1994-07-19	Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same
AU3008892A (en)	1993-06-17	Tumor associated monoclonal antibody 88bv59
GB9519460D0 (en)	1995-11-22	Polyclonal antibodies and their use